Obdulia Rabal
Harvard University(US)Universidad de Navarra(ES)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Histone Deacetylase Inhibitors Research, Biomedical Text Mining and Ontologies, Epigenetics and DNA Methylation, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → The CHEMDNER corpus of chemicals and drugs and its annotation principles(2015)416 cited
- → Information Retrieval and Text Mining Technologies for Chemistry(2017)290 cited
- → CHEMDNER: The drugs and chemical names extraction challenge(2015)268 cited
- → Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression(2019)187 cited
- → Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies(2017)166 cited
- → Dual Targeting of Histone Methyltransferase G9a and DNA‐Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma(2018)125 cited
- → APIF: A New Interaction Fingerprint Based on Atom Pairs and Its Application to Virtual Screening(2009)115 cited
- → A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer’s Disease Mice(2016)103 cited
- → Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer’s Disease(2016)85 cited
- → PharmaCoNER: Pharmacological Substances, Compounds and proteins Named Entity Recognition track(2019)83 cited